Janus Henderson Venture Fund (JVTNX) is an open-end mutual fund managed by Janus Henderson Investors that seeks capital appreciation by investing primarily in common stocks of venture capital-backed growth companies. The fund focuses on early- and late-stage ventures across sectors including technology, healthcare, consumer discretionary, and financial services; it employs a fundamental, bottom-up research process emphasizing companies with scalable business models, strong management teams, and significant revenue growth potential. Holdings typically include a diversified portfolio of 40 to 70 small- and mid-cap U.S. companies, such as those in software, biotechnology, and internet services, with an average market capitalization under $5 billion.
The fund offers institutional, retail, and retirement share classes with varying expense ratios, including no-load options for certain investors; it provides daily liquidity, professional portfolio management by experienced analysts, and quarterly reporting on performance metrics like NAV, total return, and risk-adjusted metrics. Geographically, it operates with a U.S.-centric focus but includes select international venture opportunities; Janus Henderson Investors, headquartered in London with major U.S. operations in Denver, Colorado, traces its roots to the 1930s through predecessor firms.
In recent developments, Janus Henderson announced strategic enhancements to its venture capital capabilities in 2024, including expanded dedicated resources for late-stage private investments and integration of ESG factors into selection criteria following regulatory updates. The firm completed a key acquisition of a boutique venture research team in early 2025, bolstering its pipeline analysis amid rising IPO activity; additionally, JVTNX participated in several high-profile follow-on funding rounds for portfolio companies transitioning to public markets, reflecting a shift toward hybrid public-private strategies in a recovering venture environment.